Background Several biomarkers have been proposed to predict the occurrence of acute
kidney injury (AKI); however, their efficacy varies between different trials. The aim of this …

The COVID-19 pandemic has necessitated the development of reliable diagnostic methods
for accurately detecting the novel coronavirus and its variants. Deep learning (DL) …

Purpose To develop a model to predict the use of renal replacement therapy (RRT) in
COVID-19 patients. Materials and methods Retrospective analysis of multicenter cohort of …

Rationale & Objective Patients hospitalized with COVID-19 are at increased risk for major
adverse kidney events (MAKE). We sought to identify plasma biomarkers predictive of MAKE …

Abstract The coronavirus disease-2019 (COVID-19) outbreak has been declared a global
pandemic. COVID-19-associated acute kidney injury (COVID-19 AKI) is related to a high …

Cystatin C is a specific biomarker of kidney function. We perform this meta-analysis to
determine the association of Cystatin C with the COVID-19 severity. In this systematic review …

Tubular injury is the main cause of acute kidney injury (AKI) in critically ill COVID-19
patients. Proximal tubular dysfunction (PTD) and changes in urinary biomarkers, such as …

Background A strong association between elevated neutrophil extracellular trap (NET)
levels and poor clinical outcomes in patients with coronavirus infection 2019 (COVID-19) …

In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the
serum of 120 COVID-19 patients, of whom 70 had chronic kidney disease. All the samples …

Neutrophil gelatinase-associated lipocalin (NGAL) is a novel kidney injury and inflammation
biomarker. We investigated whether NGAL could be used to predict continuous renal …